MERCER GLOBAL ADVISORS INC /ADV
Position in ELDN — Eledon Pharmaceuticals, Inc.
CIK 853758
DENVER, CO
Position in ELDN
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$131,986
+$85,349 QoQ
Shares Held
33,499
+121.2% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 159 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in ELDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MERCER GLOBAL ADVISORS INC /ADV holds $302,411,362 across 140 Biotechnology names. ELDN ranks #100 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
941,283 | $124,936,492 | |
| 2 | CAPR |
Capricor Therapeutics, Inc.
|
802,732 | $19,329,786 | |
| 3 | ORMP |
Oramed Pharmaceuticals Inc.
|
3,810,540 | $18,328,697 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,705 | $15,252,094 | |
| 5 | INCY |
Incyte Corp
|
116,207 | $13,173,225 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
20,126 | $12,549,366 | |
| 7 | EXEL |
Exelixis, Inc.
|
176,339 | $9,594,604 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
102,823 | $8,940,459 |
All Filings in ELDN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $131,986 | 33,499 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $46,637 | 15,142 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $26,702 | 17,684 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $43,519 | 16,803 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $45,327 | 16,726 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $56,701 | 16,726 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $68,911 | 16,726 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $41,647 | 16,726 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $44,156 | 16,726 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $34,455 | 16,726 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $30,106 | 16,726 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $22,914 | 16,726 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $22,914 | 16,726 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $39,473 | 16,726 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $38,135 | 16,726 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $46,163 | 16,726 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $40,811 | 16,726 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $65,900 | 16,726 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $73,761 | 16,726 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $103,366 | 16,726 | Shares | Sole | 2021-11-10 | |
| No filing history on record for this holder in this stock. | ||||||